140 related articles for article (PubMed ID: 29932858)
41. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
[TBL] [Abstract][Full Text] [Related]
42. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathologic analysis of a large series of microinvasive breast cancers.
Lillemoe TJ; Tsai ML; Swenson KK; Susnik B; Krueger J; Harris K; Rueth N; Grimm E; Leach JW
Breast J; 2018 Jul; 24(4):574-579. PubMed ID: 29476574
[TBL] [Abstract][Full Text] [Related]
44. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
45. Factors predicting microinvasion in Ductal Carcinoma in situ.
Ozkan-Gurdal S; Cabioglu N; Ozcinar B; Muslumanoglu M; Ozmen V; Kecer M; Yavuz E; Igci A
Asian Pac J Cancer Prev; 2014; 15(1):55-60. PubMed ID: 24528005
[TBL] [Abstract][Full Text] [Related]
46. Reporting the greatest linear extent of ductal carcinoma in situ on needle core biopsy.
Reisenbichler ES; Hameed O
Hum Pathol; 2016 Apr; 50():140-5. PubMed ID: 26997448
[TBL] [Abstract][Full Text] [Related]
47. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease?
Zunzunegui RG; Chung MA; Oruwari J; Golding D; Marchant DJ; Cady B
Arch Surg; 2003 May; 138(5):537-40. PubMed ID: 12742959
[TBL] [Abstract][Full Text] [Related]
48. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
[TBL] [Abstract][Full Text] [Related]
49. Ductal carcinoma in situ (DCIS) in Karachi.
Kayani N; Bhurgri Y
J Pak Med Assoc; 2005 May; 55(5):199-202. PubMed ID: 15960285
[TBL] [Abstract][Full Text] [Related]
50. The role of sentinel lymph node biopsy in ductal carcinoma in situ.
Moran CJ; Kell MR; Kerin MJ
Eur J Surg Oncol; 2005 Dec; 31(10):1105-11. PubMed ID: 16084681
[TBL] [Abstract][Full Text] [Related]
51. Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.
Fang Y; Wu J; Wang W; Fei X; Zong Y; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
Oncotarget; 2016 Sep; 7(39):64182-64190. PubMed ID: 27577080
[TBL] [Abstract][Full Text] [Related]
52. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
Renshaw AA; Derhagopian RP; Martinez P; Gould EW
Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
[TBL] [Abstract][Full Text] [Related]
53. Histologic and radiographic analysis of ductal carcinoma in situ diagnosed using stereotactic incisional core breast biopsy.
Bonnett M; Wallis T; Rossmann M; Pernick NL; Carolin KA; Segel M; Bouwman D; Visscher D
Mod Pathol; 2002 Feb; 15(2):95-101. PubMed ID: 11850537
[TBL] [Abstract][Full Text] [Related]
54. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
55. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
van Roozendaal LM; Goorts B; Klinkert M; Keymeulen KBMI; De Vries B; Strobbe LJA; Wauters CAP; van Riet YE; Degreef E; Rutgers EJT; Wesseling J; Smidt ML
Breast Cancer Res Treat; 2016 Apr; 156(3):517-525. PubMed ID: 27083179
[TBL] [Abstract][Full Text] [Related]
56. Ductal carcinoma in situ: Is core needle biopsy ever enough?
Caswell-Smith P; Wall M
J Med Imaging Radiat Oncol; 2017 Feb; 61(1):29-33. PubMed ID: 27554420
[TBL] [Abstract][Full Text] [Related]
57. [Benefit of sentinel node biopsy in patients with breast ductal carcinoma in situ].
Rubio IT; Roca I; Sabadell D; Xercavins J
Cir Esp; 2009 Feb; 85(2):92-5. PubMed ID: 19231464
[TBL] [Abstract][Full Text] [Related]
58. Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy.
Lee KH; Han JW; Kim EY; Yun JS; Park YL; Park CH
BMC Cancer; 2019 Dec; 19(1):1201. PubMed ID: 31822268
[TBL] [Abstract][Full Text] [Related]
59. Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?
Graña-López L; Herranz M; Domínguez-Prado I; Argibay S; Villares Á; Vázquez-Caruncho M
Eur Radiol; 2020 Jan; 30(1):514-522. PubMed ID: 31375867
[TBL] [Abstract][Full Text] [Related]
60. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
